Hulsman Alma H, Breur Johannes M P J, Szatmári Viktor
Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Department of Pediatric Cardiology, Wilhelmina Children's Hospital, University Medical Centre, Utrecht, The Netherlands.
J Vet Intern Med. 2021 Jan;35(1):98-106. doi: 10.1111/jvim.15966. Epub 2020 Nov 26.
Minimally invasive transcatheter occlusion using Amplatz canine duct occluder (ACDO) is the treatment of choice for dogs with left-to-right shunting patent ductus arteriosus (PDA). However, in small dogs the femoral artery diameter is often too small to accommodate the guiding catheter required for ACDO deployment.
Describe the effectiveness of transarterial implantation of Amplatzer Vascular Plug 4 (AVP-4), the only self-expandable nitinol mesh occlusion device which can be implanted through a 4 French diagnostic catheter, in small dogs with left-to-right shunting PDA.
Seven client-owned dogs.
Descriptive case series. Dogs with hemodynamically relevant left-to-right shunting PDA and a femoral artery diameter less than 2.0 mm measured preoperatively with ultrasonography were prospectively enrolled.
Angiography after releasing the device showed complete immediate PDA closure in 5 dogs, where the manufacturers' recommendation were strictly followed (30%-50% device oversizing of the ductal ampulla's diameter). Trivial residual flow on angiography in the 6th dog, whose device was slightly undersized, had resolved on echocardiography within 2 hours after placement. Marked device undersizing in the 7th dog resulted in severe residual shunting, which necessitated the addition of a coil. In this dog, the AVP-4 embolized into the pulmonary artery within 2 weeks after placement.
Transarterial implantation of AVP-4 is a safe, effective and technically easy procedure for PDA occlusion in small dogs and offers a valuable alternative to coil implantation. Accurate PDA measurement and device sizing is essential to prevent residual shunting, inadvertent device embolization, and protrusion of the device into the aorta.
使用安谱达犬用导管封堵器(ACDO)进行微创经导管封堵是左向右分流型动脉导管未闭(PDA)犬的首选治疗方法。然而,在小型犬中,股动脉直径通常过小,无法容纳ACDO部署所需的引导导管。
描述经动脉植入Amplatzer血管封堵器4(AVP-4)的有效性,AVP-4是唯一可通过4法国诊断导管植入的自膨胀镍钛合金网状封堵装置,用于治疗左向右分流型PDA的小型犬。
7只客户拥有的犬。
描述性病例系列。前瞻性纳入术前经超声测量股动脉直径小于2.0 mm且具有血流动力学相关左向右分流型PDA的犬。
释放装置后的血管造影显示,5只犬的PDA立即完全闭合,严格遵循了制造商的建议(封堵器尺寸比导管壶腹直径大30%-50%)。第6只犬的封堵器尺寸略小,血管造影显示有微量残余血流,放置后2小时内心脏超声检查显示残余血流消失。第7只犬的封堵器尺寸明显过小,导致严重残余分流,需要加用弹簧圈。在这只犬中,AVP-4在放置后2周内栓塞入肺动脉。
经动脉植入AVP-4是小型犬PDA封堵的一种安全、有效且技术上简单的方法,为弹簧圈植入提供了一种有价值的替代方法。准确测量PDA并确定封堵器尺寸对于防止残余分流、封堵器意外栓塞以及封堵器突入主动脉至关重要。